DENVER and TORONTO, May 29, 2019 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that the Company has agreed with its senior lender to amend certain terms associated with its borrowing obligations (the “Agreement”).
The Agreement provides for a revised maturity of MJardin’s senior debt to April 2021 and removes the callable nature of the loan. In addition, the senior lender has agreed to provide up to CAD$20MM in additional borrowings.
“Our senior lender remains a supportive partner, committed to MJardin’s long-term growth,” commented Adrian Montgomery, Chairman and Interim CEO. “This amendment represents a significant improvement to our balance sheet and puts MJardin on a clear path to achieve our plans in the coming years. This transaction bolsters our ability to execute predictable results in the markets we presently serve, and will help us to deliver enhanced growth in new markets and verticals.”
As a result of the amendment, the Company’s management and board reaffirms its confidence in executing the previously disclosed 2019 and 2020 business plans.
About MJardin Group
MJardin is a cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada. For more information, please visit www.mjardin.com
The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.